Traditional Chinese medicinal composition for treating aplastic anemia

Abstract

The invention discloses a traditional Chinese medicinal composition for treating aplastic anemia. The traditional Chinese medicinal composition comprises, by weight, 10-30 parts of Semen Cuscutae, 10-20 parts of mulberries, 10-20 parts of Rhizoma Imperatae, 5-15 parts of Radix Polygoni Multiflori Preparata, 10-20 parts of tortoise plastrons, 10-20 parts of Swertia Heterantha Ling, 10-20 parts of lithospermum, 5-15 parts of Fructus Ligustri Lucidi, 10-20 parts of Radix Glehniae, 10-20 parts of Cynomorium Songaricum, 5-15 parts of Lucid Ganoderma, 10-20 parts of loosestrife, 10-20 parts of Caulis Spatholobi, 10-20 parts of dried mussels, 5-15 parts of cloves, 10-20 parts of dried longan pulp, 10-20 parts of Caulis Sargentodoxae, 10-20 parts of Herminium Lanceum, 5-15 parts of Folium Artemisiae Argyi, 10-20 parts of Radix Rhapontici, 10-20 parts of motherwort and 5-15 parts of glycyrrhiza. The traditional Chinese medicinal composition has the advantages of the effect of tonifying liver, kidney, spleen and stomach, clearing toxic materials, eliminating pathogenic factors, tonifying qi, enriching blood, dredging collaterals and promoting blood circulation and the remarkable and reliable curative effect on the aplastic anemia.

Description

technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating aplastic anemia. Background technique [0002] Aplastic anemia (referred to as "Aplastic anemia") is a group of syndromes caused by a variety of factors that reduce the total volume of red bone marrow, hematopoietic failure, and pancytopenia as the main manifestation. The prevalence of aplastic anemia in my country is relatively high, about 4 times that of European and American countries. Generally manifested as anemia, bleeding, infection, fever (high or low fever), accompanied by walking fatigue, dizziness and other symptoms. Doctor trained in Western medicine thinks that causing this disease is mainly relevant with factors such as medicine, chemistry, radiation, biology, heredity. At present, the treatment of aplastic anemia is mainly to improve the hematopoietic microenvironmen...

AI Technical Summary

Problems solved by technology

At present, the treatment of aplastic anemia is mainly to improve the hematopoietic microenvironment of patients by taking immune preparations. Although the effect is remarkable, the side effects are relatively large, and long-term use may cause lesions in other organs, such as nervous system disorders, etc.